ProCE: The Pharmacy Practice Podcast-logo

ProCE: The Pharmacy Practice Podcast

Education Podcasts

Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.

Location:

United States

Description:

Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.

Language:

English


Episodes
Ask host to enable sharing for playback control

How Primary Care Providers Can Expand Their Role in HBV Management

4/26/2024
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Presenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral Hepatitis Programs Cooperman Barnabas Medical Center RWJBarnabas-Rutgers Medical Group Associate Member Health Care Policy and Aging Research The Rutgers Institute for Health Senior Advisor Global Health, Hepatitis B Foundation Florham Park, New Jersey Richard R. Andrews, MD, MPH President, Houston Viral Hepatitis Task Force Former Co-Chair, National Task Force on Hepatitis B Board-Certified Family Medicine Addiction Medicine Physician Houston, Texas Ruth Brogden, MPH Patient Advocate Amy S. Tang, MD Former Co-Chair, National Task Force on Hepatitis B Director of Immigrant Health North East Medical Services San Francisco, California Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/44hXpHu Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Duration:00:18:52

Ask host to enable sharing for playback control

How to Implement Earlier Hepatitis B Treatment

3/26/2024
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University School of Medicine Baltimore, Maryland Tatyana Kushner, MD, MSCE Associate Professor Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Palo Alto, California Jacki Chen, PhD Patient Advocate Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4a60GM4 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Duration:00:21:27

Ask host to enable sharing for playback control

How to Implement Earlier Hepatitis B and Hepatitis Delta Screening

12/22/2023
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Presenters: Douglas Dieterich, MD Director, Institute for Liver Medicine Professor of Medicine Division of Liver Diseases Mount Sinai School of Medicine New York, New York Camilla S. Graham, MD, MPH Co-Director, Viral Hepatitis Clinic Division of Infectious Diseases Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Robert Wong, MD, MS Clinical Associate Professor Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto, California Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4atS42z

Duration:00:27:52

Ask host to enable sharing for playback control

CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia

12/7/2023
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: Faculty: Julie Ann Justo, PharmD, MS, FIDSA, BCPS Clinical Pharmacist Lead – Infectious Diseases Inpatient Pharmacy Dartmouth Hitchcock Medical Center Lebanon, New Hampshire Link to full program: https://bit.ly/41a8Mj0 Link to accompanying ClinicalThought commentary: https://bit.ly/4865T57 Link to downloadable infographic: https://bit.ly/3t7NpT2

Duration:00:15:53

Ask host to enable sharing for playback control

Trailblazers: Pharmacist’s Role in Optimizing New RSV Vaccines for Older Adults

11/27/2023
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman provide practical strategies for implementing RSV vaccination into practice, including: Presenters: Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, New Jersey Internal Medicine Pharmacist Robert Wood Johnson University Hospital New Brunswick, New Jersey Christina M. Madison, PharmD, FCCP, AAHIVP Clinical Pharmacist Founder and CEO, The Public Health Pharmacist, PLLC Adjunct Associate Professor of Pharmacy Practice Roseman University of Health Sciences College of Pharmacy Henderson, Nevada Other program activities: https://bit.ly/49GUv1gLink to CME: Claim Credit – https://bit.ly/3uoY7VH [After selecting the “Continue to Post Test” button:] To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.

Duration:00:19:46

Ask host to enable sharing for playback control

Light on the Horizon: Developments in RSV Vaccines

11/21/2023
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including: Presenters: Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, New Jersey Internal Medicine Pharmacist Robert Wood Johnson University Hospital New Brunswick, New Jersey Christina M. Madison, PharmD, FCCP, AAHIVP Clinical Pharmacist Founder and CEO, The Public Health Pharmacist, PLLC Adjunct Associate Professor of Pharmacy Practice Roseman University of Health Sciences College of Pharmacy Henderson, Nevada Other program activities: • Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role

Duration:00:16:47

Ask host to enable sharing for playback control

Surveying the Landscape: Annual Burden of RSV in Older Adults

11/21/2023
In this accredited podcast episode, Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including: Presenter: Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, New Jersey Internal Medicine Pharmacist Robert Wood Johnson University Hospital New Brunswick, New Jersey Other program activities: https://bit.ly/49GUv1gLink to CME: Claim Credit – https://bit.ly/47GtNnK [After selecting the “Continue to Post Test” button:] To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.

Duration:00:12:52

Ask host to enable sharing for playback control

Our Experiences With the Latest Treatment Options in Ovarian Cancer: The Pharmacist Perspective

6/28/2023
In this episode, Sarah Hayward, PharmD, BCOP, and Amy Ly Indorf, PharmD, BCOP, discuss their experiences providing care for patients with advanced ovarian cancer, with topics including: Presenters: Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology Stephenson Cancer Center at OU Health Oklahoma City, Oklahoma Amy Ly Indorf, PharmD, BCOP Clinical Assistant Professor University of Washington School of Pharmacy Clinical Oncology Pharmacist UW Medicine Fred Hutchinson Cancer Center Seattle, Washington Supported by educational grants from GSK and Novocure, Inc. Link to full program: https://bit.ly/44fUiOU

Duration:00:15:08

Ask host to enable sharing for playback control

2023 Audio Recap: Principles of Outpatient COVID-19 Management

5/3/2023
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Presenters: Renslow Sherer, MD Director, International HIV Training Center Professor of Medicine Section of Infectious Diseases and Global Health Department of Medicine University of Chicago Chicago, Illinois Trinh P. Vu, PharmD, BCIDP Clinical Pharmacy Specialist in Infectious Diseases Department of Pharmaceutical Services Emory University Hospital Midtown Atlanta, Georgia To download the slides: bit.ly/3oHKC09 To view the full online program: bit.ly/4201xcO

Duration:01:14:42

Ask host to enable sharing for playback control

GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes

11/4/2022
In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes. Presenters: Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM Clinical Professor Department of Pharmacy Practice Auburn University Harrison College of Pharmacy Clinical Pharmacist Baptist Health Foundation Center for Medical and Surgical Care Princeton Baptist Medical Center/Brookwood Baptist Health Birmingham, Alabama Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor Department of Pharmacy Practice Midwestern University College of Pharmacy Downers Grove, Illinois Clinical Pharmacist Advocate Medical Group Chicago, Illinois Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc. Link to full program: https://bit.ly/3Un1xQi

Duration:00:22:34

Ask host to enable sharing for playback control

Pearls on the Role of Mineralocorticoid Receptor Antagonists and the Impact on Patient Care in CKD in T2D

5/17/2022
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including: Presenter: Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Endocrine Clinical Pharmacy Specialist CGM and Remote Monitoring Program Coordinator Endocrinology and Metabolism Institute Cleveland Clinic Cleveland, Ohio Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Vice Chair and Allen I. White Distinguished Professor Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University Spokane, Washington Review the downloadable slideset and the full program at: https://bit.ly/3wxNAod

Duration:00:29:13

Ask host to enable sharing for playback control

Cardiology Pharmacist’s Insights on Patient Engagement, Healthcare Provider Collaboration, and Reducing Disparities

4/26/2022
This podcast is the third in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, pharmacist Kathleen A. Lusk, PharmD, BCPS, BCCP, provides an overview of health disparities, patient engagement, and collaborative team-based care to optimize outcomes for patients with NVAF. Dr Lusk reviews best practices in using the principles of motivational interviewing to employ shared decision-making and models these strategies with 2 simulated clinical patient visits. Common barriers, such as medication access and adherence, also are discussed, along with practical solutions for overcoming these care obstacles. Presenter: Kathleen A. Lusk, PharmD, BCPS, BCCP Associate Professor and Vice Chair Department of Pharmacy Practice University of the Incarnate Word Feik School of Pharmacy Adjunct Assistant Professor Clinical Pharmacy Specialist Division of Cardiology Department of Medicine UT Health San Antonio San Antonio, Texas Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance. This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to: https://bit.ly/3OMazV8

Duration:00:30:46

Ask host to enable sharing for playback control

Cardiology Pharmacist’s Insights on Stroke Prevention in NVAF With Evidence-Based DOAC Therapy

4/25/2022
This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2-VASc to design patient-specific pharmacotherapy plans; and the use of DOACs in special patient populations, including older patients, patients with end-stage renal disease, and patients with low or high body weights. Presenter: Stephanie Dwyer Kaluzna, PharmD, BCCP Clinical Assistant Professor Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Cardiovascular Clinical Pharmacist University of Illinois Hospital and Health Science System Chicago, Illinois Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance. This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to https://bit.ly/3OMazV8

Duration:00:28:26

Ask host to enable sharing for playback control

Cardiology Pharmacists’ Insights on Recognizing the Burden of NVAF and Role of Screening in Pharmacy Settings

4/25/2022
This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings. Presenters: Kathleen A. Lusk, PharmD, BCPS, BCCP Associate Professor and Vice Chair Department of Pharmacy Practice University of the Incarnate Word Feik School of Pharmacy Adjunct Assistant Professor Clinical Pharmacy Specialist Division of Cardiology Department of Medicine UT Health San Antonio San Antonio, Texas Stephanie Dwyer Kaluzna, PharmD, BCCP Clinical Assistant Professor Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Cardiovascular Clinical Pharmacist University of Illinois Hospital and Health Science System Chicago, Illinois Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance. This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to https://bit.ly/3OMazV8

Duration:00:30:13

Ask host to enable sharing for playback control

Best Practices for Pharmacists to Optimize Use of Obesity Treatment Options and Overcome Barriers to Care

4/22/2022
In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care. Presenters: Megan Adelman, PharmD, BCPS, BCGP, CDCES Family Medicine Clinical Specialist Center for Family Medicine Cleveland Clinic Akron General Akron, Ohio Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA Professor Department of Pharmacy Practice College of Pharmacy-Glendale Midwestern University Glendale, Arizona Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc. Link to full program: https://bit.ly/3EAARVu

Duration:01:19:58

Ask host to enable sharing for playback control

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists

1/7/2022
Faculty Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Critical Care Pharmacy Specialist, Department of Pharmacy University of Colorado Hospital Aurora, Colorado Charles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCP Adjunct Associate Professor, Pharmacy University of New Mexico Health Sciences Center Albuquerque, New Mexico Content based on a CE activity supported by an educational grant from Alexion, AstraZeneca Rare Disease. Link to full activity: https://www.proce.com/Anticoagulation

Duration:00:42:53

Ask host to enable sharing for playback control

Pharmacists’ Perspective on Managing Multiple Myeloma: FAQs

9/17/2021
1:08 - Take-home thoughts for R/R MM 3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM 6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice 9:59 - Cost considerations for treatment options in R/R MM 12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MM Faculty Kathryn Maples, PharmD, BCOP Clinical Pharmacy Specialist, Multiple Myeloma Winship Cancer Institute, Emory Healthcare Atlanta, Georgia Tim Peterson, PharmD, BCOP Clinical Pharmacy Specialist – Multiple Myeloma Memorial Sloan Kettering Cancer Center New York, New York Content based on a CE activity supported by educational grants from Karyopharm Therapeutics, Inc. and Oncopeptides, Inc. Link to full activity: https://www.proce.com/RRMM

Duration:00:08:42